• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.03% Nasdaq Up0.29%

    Amyris, Inc. (AMRS)

    1.84 0.01(0.54%) Jan 26, 4:00PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Amyris, Inc.
    5885 Hollis Street
    Suite 100
    Emeryville, CA 94608
    United States - Map
    Phone: 510-450-0761
    Fax: 510-225-2645
    Website: http://www.amyris.com

    Index Membership:N/A
    Sector:Basic Materials
    Industry:Specialty Chemicals
    Full Time Employees:403

    Business Summary 

    Amyris, Inc., a renewable products company, provides various alternatives to a range of petroleum-sourced products for the specialty chemical and transportation fuel markets worldwide. It builds and applies its industrial synthetic biology platform to design microbes, primarily yeast, to convert plant-sourced sugars into renewable hydrocarbons. The company produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products. It also provides Biofene for specialty chemical applications and transportation fuels, such as diesel. In addition, the company is involved in the development, production, and commercialization of renewable base oils, as well as additives and lubricants for the automotive, industrial, and commercial lubricants markets; and offers natural oils and aroma chemicals for the flavors and fragrances market. It has a strategic partnership with Total for the production and commercialization of diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Amyris, Inc.

    Corporate Governance 
    Amyris, Inc.’s ISS Governance QuickScore as of Jan 1, 2015 is 10. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 8; Compensation: 10.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Mr. John G. Melo , 49
    Chief Exec. Officer, Pres and Director
    Dr. Joel R. Cherry Ph.D., 54
    Pres of R&D
    Mr. Raffi Mark Asadorian , 46
    Chief Financial Officer
    Dr. Jack D. Newman Ph.D., 48
    Chief Science Officer
    Mr. Nicholas S. Khadder , 41
    Sr. VP, Gen. Counsel and Corp. Sec.
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders